Overview

Gender

male

Chairman and Chief Executive Officer David D. Halbert is a proven leader with a strong track record of growth and value creation in the energy, financial and healthcare industries. With more than 40 years of experience, Mr. Halbert continues to be one of the most successful entrepreneurs in this country. Today, Mr. Halbert is a passionate advocate of personalized medicine and leads Caris Life Sciences® with a philosophy that more precise and individualized information will lead to dramatic improvements in the quality of care patients receive. Mr. Halbert has been tremendously influenced by his mother’s passing over a decade ago due to cancer, as evidenced by his investment, commitment, and unwavering dedication to making precision medicine a reality for cancer patients today.

Prior to founding Caris Life Sciences, Mr. Halbert founded AdvancePCS® in 1987, a leading pharmacy benefits management company, where he served as Chairman and CEO until it was sold to CareMark® in 2004 for $7.5 billion. Under Mr. Halbert’s leadership, the small, privately-owned company grew into a publicly traded, Fortune® 250 corporation with over $15 billion in annual revenue – taking a leadership position with its health improvement offerings. AdvancePCS served more than 75 million people – one in every four Americans – and managed 600 million prescription transactions annually, representing approximately $28 billion in drug expenditures. Focused on advancing quality of care while lowering healthcare costs, Mr. Halbert supplemented internal development with eleven strategic acquisitions, all successful, and posted 38 consecutive quarters of record-breaking earnings per share, including an unparalleled 147% compounded annual revenue growth over 14 consecutive years. When AdvancePCS was sold, it returned 31 times its initial public offering (IPO) value, 150 times the venture capital investment made by J.H. Whitney, and Caanan Partners in 1993, and 227 times the original investors’ money.